| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.AJOG.2008.06.094 |
| P698 | PubMed publication ID | 19084096 |
| P50 | author | Adam L Hartman | Q38324248 |
| Frances J Northington | Q105948294 | ||
| P2093 | author name string | Ernest M Graham | |
| Harold E Fox | |||
| Kristy A Ruis | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| systematic review | Q1504425 | ||
| maternal health | Q6786626 | ||
| P304 | page(s) | 587-595 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy | |
| P478 | volume | 199 |
| Q41528807 | A Controversial Medicolegal Issue: Timing the Onset of Perinatal Hypoxic-Ischemic Brain Injury. |
| Q54969494 | A longitudinal 1H-NMR metabolomics analysis of urine from newborns with hypoxic-ischemic encephalopathy undergoing hypothermia therapy. Clinical and medical legal insights. |
| Q34937745 | A novel AP4M1 mutation in autosomal recessive cerebral palsy syndrome and clinical expansion of AP-4 deficiency |
| Q35815260 | A pilot cohort study of cerebral autoregulation and 2-year neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy who received therapeutic hypothermia |
| Q43410729 | A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E₂ (OPRA study). |
| Q51045650 | A simulation model to study maternal hyperoxygenation during labor. |
| Q35082601 | Adherence to hypothermia guidelines: a French multicenter study of fullterm neonates |
| Q36336758 | Adiponectin, leptin and insulin levels at birth and in early postnatal life in neonates with hypoxic ischemic encephalopathy |
| Q34123917 | Adverse obstetric events are associated with significant risk of cerebral palsy |
| Q41892205 | An automated system for grading EEG abnormality in term neonates with hypoxic-ischaemic encephalopathy |
| Q37980082 | An interdisciplinary fetal/neonatal neurology program |
| Q54336494 | Ante- and intrapartum risk factors for neonatal hypoxic ischemic encephalopathy. |
| Q33819674 | Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry |
| Q36254898 | Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse |
| Q34143980 | Association of Apgar scores with death and neurologic disability |
| Q34272422 | Association of NOS3 gene variants and clinical contributors of hypoxic-ischemic encephalopathy |
| Q36464580 | Bax inhibiting peptide reduces apoptosis in neonatal rat hypoxic-ischemic brain damage |
| Q93029152 | Birth Injury: Birth Asphyxia and Birth Trauma |
| Q100464964 | Blood biomarkers for neonatal hypoxic-ischemic encephalopathy in the presence and absence of sentinel events |
| Q31033989 | Brain Injury and Inflammatory Response to Umbilical Cord Occlusions Is Limited With Worsening Acidosis in the Near-Term Ovine Fetus |
| Q64959737 | C-type natriuretic peptide functions as an innate neuroprotectant in neonatal hypoxic-ischemic brain injury in mouse via natriuretic peptide receptor 2. |
| Q57169538 | Cardiotocography and beyond: a review of one-dimensional Doppler ultrasound application in fetal monitoring |
| Q34979293 | Cerebrovascular autoregulation after rewarming from hypothermia in a neonatal swine model of asphyxic brain injury |
| Q37638583 | Cerebrovascular autoregulation and neurologic injury in neonatal hypoxic-ischemic encephalopathy. |
| Q51760374 | Combination of Constraint-Induced Movement Therapy with Electroacupuncture Improves Functional Recovery following Neonatal Hypoxic-Ischemic Brain Injury in Rats. |
| Q60915710 | Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility |
| Q52641435 | Combined prediction of miR-210 and miR-374a for severity and prognosis of hypoxic-ischemic encephalopathy. |
| Q48203349 | Comment and reply on: Neonatal asphyxia and forensic medicine |
| Q27006952 | Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy |
| Q38364327 | Current proceedings of cerebral palsy. |
| Q41469526 | Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial. |
| Q36066674 | De novo point mutations in patients diagnosed with ataxic cerebral palsy. |
| Q36972470 | Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti-inflammatory pathway? |
| Q34102174 | Diagnostic accuracy of fetal heart rate monitoring in the identification of neonatal encephalopathy |
| Q36503058 | Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation |
| Q33667312 | Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. |
| Q44263338 | Dopamine infusion for postresuscitation blood pressure support after profound asphyxia in near-term fetal sheep |
| Q45093240 | Dynamic changes of cerebral-specific proteins in full-term newborns with hypoxic-ischemic encephalopathy |
| Q64230537 | Effect of erythropoietin on Fas/FasL expression in brain tissues of neonatal rats with hypoxic-ischemic brain damage |
| Q86359814 | Electronic Fetal Monitoring: A Defense Lawyer's View |
| Q34431340 | Elevated levels of serum sICAM-1 in asphyxiated low birth weight newborns |
| Q35471285 | Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy |
| Q36277628 | Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics |
| Q38387887 | Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy? |
| Q55240617 | Expression and functions of glutamate and γ‑aminobutyric acid transporters in ischemic models. |
| Q58795913 | Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants |
| Q37708913 | Fetal hypoxia increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of glucocorticoid receptors. |
| Q53089479 | Formal training in general movement assessment is required to effectively evaluate infants with perinatal asphyxia in outpatient settings. |
| Q35810334 | Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies |
| Q33570294 | Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling |
| Q37061164 | Glial-Restricted Precursors Protect Neonatal Brain Slices from Hypoxic-Ischemic Cell Death Without Direct Tissue Contact |
| Q43793335 | Has the incidence of hypoxic ischaemic encephalopathy in Queensland been reduced with improved education in fetal surveillance monitoring? |
| Q48427292 | Heart rate variability in hypoxic ischemic encephalopathy during therapeutic hypothermia |
| Q48337609 | Heart rate variability in hypoxic ischemic encephalopathy: correlation with EEG grade and 2-y neurodevelopmental outcome |
| Q33961885 | Hypothermia for hypoxic-ischemic encephalopathy |
| Q35209809 | Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments |
| Q33770270 | Hypoxic-ischemic encephalopathy in the term infant |
| Q47848019 | Identification of cases with adverse neonatal outcome monitored by cardiotocography versus ST analysis: secondary analysis of a randomized trial |
| Q30425752 | Impact of kangaroo mother care on cerebral blood flow of preterm infants |
| Q35064218 | Impact of perinatal systemic hypoxic-ischemic injury on the brain of male offspring rats: an improved model of neonatal hypoxic-ischemic encephalopathy in early preterm newborns |
| Q34297349 | Interleukin-1 receptor blockade in perinatal brain injury |
| Q35420393 | Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions |
| Q34542001 | Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement |
| Q34132056 | Intraoperative blood pressure and cerebral perfusion: strategies to clarify hemodynamic goals |
| Q52642366 | Intrauterine resuscitation during the second stage of term labour by maternal hyperoxygenation versus conventional care: study protocol for a randomised controlled trial (INTEREST O2). |
| Q50583315 | L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. |
| Q37282809 | Magnetic resonance imaging spectrum of perinatal hypoxic-ischemic brain injury |
| Q48110948 | Maternal Oxytocin Administration Before Birth Influences the Effects of Birth Anoxia on the Neonatal Rat Brain |
| Q33774205 | Maternal or neonatal infection: association with neonatal encephalopathy outcomes |
| Q50664000 | Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs. |
| Q37302940 | Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel? |
| Q35921652 | Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity? |
| Q28385013 | Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns |
| Q34546178 | Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy |
| Q37726975 | Moderate hypothermia: is selective head cooling or whole body cooling better? |
| Q30847961 | Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges |
| Q37598147 | Neonatal asphyxia and forensic medicine |
| Q48545987 | Neonatal brain imaging and the identification of metabolic acidemia and hypoxic-ischemic encephalopathy |
| Q59584857 | Neonatal outcomes and operative vaginal delivery versus cesarean delivery |
| Q36894712 | Normal Neurodevelopmental Outcomes in PNPO Deficiency: A Case Series and Literature Review |
| Q90630331 | Offspring of rats with cerebral hypoxia-ischemia manifest cognitive dysfunction in learning and memory abilities |
| Q37848671 | Omega-3 Fatty acids and pregnancy |
| Q34491751 | Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions |
| Q43512781 | PGE-metabolite levels in CSF correlate to HIE score and outcome after perinatal asphyxia. |
| Q37402402 | Partial neuroprotection by nNOS inhibition during profound asphyxia in preterm fetal sheep. |
| Q50147546 | Patterns of brain injury in neonatal hypoxic-ischemic encephalopathy on magnetic resonance imaging: recommendations on classification |
| Q34442853 | Perinatal hypoxic-ischemic encephalopathy |
| Q36734441 | Perinatal risk factors for severe injury in neonates treated with whole-body hypothermia for encephalopathy |
| Q48239103 | Peripartum events associated with severe neurologic morbidity and mortality among acidemic neonates. |
| Q91515391 | Placental pathology and neonatal brain MRI in a randomized trial of erythropoietin for hypoxic-ischemic encephalopathy |
| Q26751830 | Plasticity in the Neonatal Brain following Hypoxic-Ischaemic Injury |
| Q50094040 | Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat. |
| Q37933352 | Postmortem cesarean: report of our successful neonatal outcomes after severe trauma during pregnancy and review of the literature |
| Q34091662 | Potential biomarkers for hypoxic-ischemic encephalopathy |
| Q89496065 | Predictions of Hypoxic-Ischemic Encephalopathy by Umbilical Cord Blood Lactate in Newborns with Birth Asphyxia |
| Q37229588 | Predictors of Mortality in Neonates with Seizures; a Prospective Cohort Study |
| Q40323930 | Pregnancy outcome and placental pathology in emergent cesarean deliveries for non-reassuring fetal heart rate in laboring versus non-laboring women |
| Q94528440 | Prevalence of perinatal asphyxia in East and Central Africa: systematic review and meta-analysis |
| Q42677471 | Rapid Generation and Detection of Biomimetic Oxygen Concentration Gradients In Vitro |
| Q38042272 | Rescuing the neonatal brain from hypoxic injury with autologous cord blood |
| Q33973513 | Risk factors for epilepsy in children with neonatal encephalopathy |
| Q26747485 | Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic Review |
| Q35528181 | Serial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model. |
| Q36395678 | Sex differences in cell genesis, hippocampal volume and behavioral outcomes in a rat model of neonatal HI |
| Q38763755 | Sex-specific associations between cerebrovascular blood pressure autoregulation and cardiopulmonary injury in neonatal encephalopathy and therapeutic hypothermia |
| Q47136617 | Shedding light on the neonatal brain: probing cerebral hemodynamics by diffuse optical spectroscopic methods |
| Q90175443 | Single-nucleotide polymorphism screening and RNA sequencing of key messenger RNAs associated with neonatal hypoxic-ischemia brain damage |
| Q36682284 | Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain |
| Q49719878 | Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs. |
| Q30495687 | TLR2 activation inhibits embryonic neural progenitor cell proliferation |
| Q47139324 | Tanshinone I alleviates motor and cognitive impairments via suppressing oxidative stress in the neonatal rats after hypoxic-ischemic brain damage. |
| Q53840058 | Temporal trends in severe maternal and neonatal trauma during childbirth: a population-based observational study. |
| Q38011443 | Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? |
| Q41330598 | The Ovine Fetal and Placental Inflammatory Response to Umbilical Cord Occlusions With Worsening Acidosis |
| Q40623587 | The association between umbilical cord abnormalities and the development of non-reassuring fetal heart rate leading to emergent cesarean deliveries |
| Q34309643 | The association of cerebral palsy with birth asphyxia: a definitional quagmire |
| Q37195403 | The burden of hypoxic-ischaemic encephalopathy in Malaysian neonatal intensive care units |
| Q45919545 | The incidence and implications of cerebral palsy following potentially avoidable obstetric complications: a preliminary burden of disease study. |
| Q45017506 | The relationship between umbilical cord arterial pH and serious adverse neonatal outcome: analysis of 51,519 consecutive validated samples |
| Q48065815 | The role of fetal inflammatory response syndrome and fetal anemia in nonpreventable term neonatal encephalopathy |
| Q41881063 | The timing of perinatal hypoxia/ischemia events in term neonates: a retrospective autopsy study. HSPs, ORP-150 and COX2 are reliable markers to classify acute, perinatal events |
| Q104495238 | Theoretical basis for the use of non-invasive thermal measurements to assess the brain injury in newborns undergoing therapeutic hypothermia |
| Q47330827 | Therapeutic Hypothermia Provides Variable Protection against Behavioral Deficits after Neonatal Hypoxia-Ischemia: A Potential Role for Brain-Derived Neurotrophic Factor |
| Q33711176 | Therapeutic Hypothermia in Asphyxiated Neonates: Experience from Neonatal Intensive Care Unit of University Hospital of Marrakech |
| Q45122641 | Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy |
| Q34163864 | Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia |
| Q48314216 | Two-year follow-up study on neurodevelopmental outcomes after term intrapartum asphyxia using age and stages questionnaire |
| Q41999373 | Umbilical Cord Blood NOS1 as a Potential Biomarker of Neonatal Encephalopathy. |
| Q48098754 | Umbilical cord blood concentrations of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in neonates developing hypoxic-ischemic encephalopathy |
| Q38972633 | Umbilical lactate as a measure of acidosis and predictor of neonatal risk: a systematic review |
| Q30378459 | Understanding the Full Spectrum of Organ Injury Following Intrapartum Asphyxia |
| Q44359599 | Usefulness of serum lipid peroxide as a diagnostic test for hypoxic ischemic encephalopathy in the full-term neonate. |
| Q33648925 | Vitexin protects against hypoxic-ischemic injury via inhibiting Ca2+/Calmodulin-dependent protein kinase II and apoptosis signaling in the neonatal mouse brain. |
| Q55439840 | Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1. |
| Q40098449 | White Matter Injury of Prematurity: Its Mechanisms and Clinical Features |
| Q36494982 | White matter apoptosis is increased by delayed hypothermia and rewarming in a neonatal piglet model of hypoxic ischemic encephalopathy |
| Q33830747 | nNOS inhibition during profound asphyxia reduces seizure burden and improves survival of striatal phenotypic neurons in preterm fetal sheep |
Search more.